A month has gone by since the last earnings report for IPG Photonics (IPGP Quick QuoteIPGP - Free Report) . Shares have lost about 16.6% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is IPG due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.

IPGP Q2 Earnings Beat Estimates on Industrial Solutions Growth

IPG Photonics Corporation reported second-quarter 2026 adjusted earnings of 58 cents per share, up 93% year over year. The figure beat the Zacks Consensus Estimate by 45%.

Revenues of $278.58 million rose 11% year over year but missed the consensus mark by 0.2%. Strong demand across Industrial Solutions, particularly battery manufacturing, supported growth. Emerging growth products represented 58% of revenues, up from 53% in the prior quarter.

IPGP Revenue Mix Tilts Toward Industrial Solutions

Industrial Solutions revenues increased 16% year over year to $237 million and accounted for 85% of total sales. Growth was driven by higher welding, marking, cleaning and additive manufacturing revenues. Sequentially, the segment advanced 4%, led by welding and cleaning applications.

Battery manufacturing remained an important demand driver for welding products. The performance helped IPGP deliver its third consecutive quarter of double-digit year-over-year revenue growth. Changes in foreign exchange rates added roughly 2% to total revenues.

IPG Photonics Sees Mixed Advanced Solutions Trends

Advanced Solutions revenues declined 9% year over year to $41.5 million. Lower micromachining and defense sales more than offset growth in semiconductor applications. However, revenues improved 10% sequentially as semiconductor and micromachining demand strengthened.

The company continues to pursue expansion opportunities in higher-growth applications. Its planned acquisition of Lumibird Medical is expected to establish a larger medical laser platform, including ophthalmology treatment and diagnostic systems, while complementing IPG Photonics’ existing urology presence.

IPGP Records Broad Growth Across Asia

Asia revenues increased 19% year over year, primarily reflecting stronger welding sales. The region also posted sequential growth as demand for Industrial Solutions remained robust.

Europe revenues rose 5% from the year-ago quarter, supported by cleaning and additive manufacturing applications. North American sales decreased 2% due to lower cutting, medical and defense revenues, although marking and defense sales improved sequentially.

IPGP Operating Details

GAAP gross margin increased 310 basis points year over year to 40.4%. Adjusted gross margin expanded 290 basis points to 40.7%. Both measures also improved sharply from the first quarter.

The margin gains reflected lower product costs, reduced inventory provisions and $4.7 million in tariff refunds recorded during the quarter. Operating expenses, excluding foreign exchange and other items, were $91.4 million, up 1% year over year but down 2% sequentially. Expenses benefited from a $1.8 million German research and development tax credit.

Adjusted EBITDA rose 54% to $48.5 million, exceeding the upper end of management’s second-quarter guidance.

Adjusted operating income surged 246% year over year to $23.9 million. 

IPG Photonics Maintains Debt-Free Balance Sheet

IPG Photonics ended the quarter with $871 million in cash and short-term investments and $33 million in long-term investments. The company had no debt.

For the second quarter of 2026, Cash generated from operations was $37.8 million.

IPGP Issues Q3 Guidance Amid Tariff Uncertainty

For the third quarter of 2026, IPGP expects revenues between $265 million and $295 million. Adjusted gross margin is projected to be in the range of 37.5% to 40.5%, while adjusted operating expenses are expected to be between $92 million and $95 million.

Adjusted earnings are forecasted to be between 30 cents and 60 cents per share. Adjusted EBITDA is expected to be in the range of $35 million-$51 million.

How Have Estimates Been Moving Since Then?

It turns out, estimates review have trended upward during the past month.

The consensus estimate has shifted 5.58% due to these changes.

VGM Scores

At this time, IPG has a nice Growth Score of B, however its Momentum Score is doing a bit better with an A. However, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy.

Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.

Outlook

Estimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, IPG has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.